TBC
BMY icon

Ted Buchan & Co’s Bristol-Myers Squibb BMY Stock Holding History

Ted Buchan & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.93M Buy
31,900
+221
+0.7% +$12.9K 0.7% 33
2025
Q4 		$1.71M Buy
31,679
+2,068
+7% +$99.5K 0.63% 36
2025
Q3 		$1.34M Buy
29,611
+2,386
+9% +$111K 0.52% 44
2025
Q2 		$1.26M Buy
27,225
+3,888
+17% +$191K 0.5% 45
2025
Q1 		$1.42M Sell
23,337
-360
-2% -$21K 0.67% 31
2024
Q4 		$1.34M Buy
23,697
+1,440
+6% +$80.5K 0.63% 33
2024
Q3 		$1.15M Buy
+22,257
New +$1.04M 0.55% 35

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ted Buchan & Co's BMY Position: Q1 2026 in Review

Ted Buchan & Co increased its Bristol-Myers Squibb (BMY) stake by 0.7% in Q1 2026, buying an estimated $12.9K and bringing the position to 31,900 shares worth $1.93M. The position accounts for 0.7% of the portfolio, ranked #33.

Ted Buchan & Co first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Ted Buchan & Co held 31,900 shares of Bristol-Myers Squibb worth $1.93M as of Q1 2026.
  • Ted Buchan & Co bought 221 Bristol-Myers Squibb shares in Q1 2026, an estimated $12.9K.
  • Bristol-Myers Squibb made up 0.7% of Ted Buchan & Co's portfolio in Q1 2026, its #33 holding.
  • Ted Buchan & Co first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ted Buchan & Co's 13F filing for Q1 2026, filed 14 May 2026.